Flow Sensors for Medical Applications
Jan 13 2020 Read 177 Times
Titan Enterprises reports on increasing use of its proprietary Atrato ultrasonic flowmeter technology for medical applications including real-time drug monitoring, metering of coolants for chemotherapy treatment and blood flow systems.
Ultrasound flow measurement has over recent years shown great promise in medical applications, initially with Doppler shift technology, and more recently with time of flight systems such as the Atrato.
Beneficially Atrato is a true inline non-invasive flowmeter technology without the contorted flow path and disadvantages of alternative ultrasonic flowmeter designs. It can handle flows from laminar to turbulent and is therefore largely immune from viscosity effects. Based upon a patented time-of-flight ultrasonic technology, Atrato is able to operate over very wide flow ranges (200:1) delivering excellent accuracy (better than ±1.0% of reading), linearity and repeatability, critical parameters for medical applications.
Also based on Atrato technology. Titan Enterprises Metraflow ultrasonic flowmeter offers the additional advantage of a clean bore with no inclusions or distortions and has proved more than adequate at responding to the dynamics of several medical blood flow systems.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Export experts talk Corona Virus - Automated cell counting shouldn’t cost the earth Laboratory Products - Spectrophotometer Linearity Validation - Analysi...
View all digital editions
Apr 13 2020 Casablanca, Morocco
Apr 26 2020 Montreal, Quebec, Canada
May 03 2020 Dublin, Ireland
May 12 2020 Oklahoma, USA
May 20 2020 Nottingham, UK